Dr Kate Eggleston
| Position | Senior Lecturer |
|---|---|
| Department | Department of Psychological Medicine (Christchurch) |
| Research summary | Mood disorders |
Research
Kate Eggleston is a Senior Lecturer at the Department of Psychological Medicine, University of Otago, Christchurch.
Kate is involved in the Departmental research projects examining the longer-term outcome of mood disorders and interventions to increase the likelihood of response and remission. Her research interests include cognitive and functional recovery in mood disorders, women's mental health and consultation liaison psychiatry. Kate is the co-convenor of fourth year medical student teaching in Older Persons Health.
Publications
Moot, W., Crowe, M., Inder, M., Eggleston, K., Frampton, C., & Porter, R. J. (2022). Domain-based functional improvements in bipolar disorder after interpersonal and social rhythm therapy. Frontiers in Psychiatry, 13, 767629. doi: 10.3389/fpsyt.2022.767629
Douglas, K., Inder, M. L., Crowe, M. T., Jordan, J., Carlye, D., Lacey, C., Beaglehole, B., Mulder, R., Eggleston, K., Donovan, K. A., Frampton, C. M. A., … Porter, R. J. (2022). Randomised controlled trial of Interpersonal and Social Rhythm Therapy and group-based Cognitive Remediation versus Interpersonal and Social Rhythm Therapy alone for mood disorders: Study protocol. BMC Psychiatry, 22, 115. doi: 10.1186/s12888-022-03747-z
Douglas, K. M., Groves, S., Crowe, M. T., Inder, M. L., Jordan, J., Carlyle, D., Wells, H., Beaglehole, B., Mulder, R., Lacey, C., Luty, S. E., Eggleston, K., Frampton, C. M. A., … Porter, R. J. (2022). A randomised controlled trial of psychotherapy and cognitive remediation to target cognition in mood disorders. Acta Psychiatrica Scandinavica, 145, 278-292. doi: 10.1111/acps.13387
Douglas, K. M., Fenton, A. J., Eggleston, K., & Porter, R. J. (2021). Rate of polycystic ovary syndrome in mental health disorders: A systematic review. Archives of Women's Mental Health. Advance online publication. doi: 10.1007/s00737-021-01179-4
Moot, W., Crowe, M., Inder, M., Eggleston, K., Frampton, C., & Porter, R. (2021). Functional and mood outcomes in bipolar disorder patients with and without substance use disorders undergoing psychotherapy. Frontiers in Psychiatry, 12, 661458. doi: 10.3389/fpsyt.2021.661458
Douglas, K. M., Groves, S., Crowe, M. T., Inder, M. L., Jordan, J., Carlyle, D., Wells, H., Beaglehole, B., Mulder, R., Lacey, C., Luty, S. E., Eggleston, K., Frampton, C. M. A., … Porter, R. J. (2022). A randomised controlled trial of psychotherapy and cognitive remediation to target cognition in mood disorders. Acta Psychiatrica Scandinavica, 145, 278-292. doi: 10.1111/acps.13387
Journal - Research Article
Moot, W., Crowe, M., Inder, M., Eggleston, K., Frampton, C., & Porter, R. J. (2022). Domain-based functional improvements in bipolar disorder after interpersonal and social rhythm therapy. Frontiers in Psychiatry, 13, 767629. doi: 10.3389/fpsyt.2022.767629
Journal - Research Article
Crowe, M., Inder, M., Porter, R., Wells, H., Jordan, J., Lacey, C., Eggleston, K., & Douglas, K. (2021). Patients' perceptions of functional improvement in psychotherapy for mood disorders. American Journal of Psychotherapy, 74(1), 22-29. doi: 10.1176/appi.psychotherapy.202020200017
Journal - Research Article
Eggleston, M., Eggleston, K., Thabrew, H., Hennig, S., & Frampton, C. (2021). Order out of chaos? Autism spectrum disorder coordinators' impact on service delivery in New Zealand. Australasian Psychiatry. Advance online publication. doi: 10.1177/10398562211009249
Journal - Research Article
Moot, W., Crowe, M., Inder, M., Eggleston, K., Frampton, C., & Porter, R. (2021). Functional and mood outcomes in bipolar disorder patients with and without substance use disorders undergoing psychotherapy. Frontiers in Psychiatry, 12, 661458. doi: 10.3389/fpsyt.2021.661458
Journal - Research Article
Sukhapure, M., Eggleston, K., Douglas, K., Fenton, A., Frampton, C., & Porter, R. J. (2021). Free testosterone is related to aspects of cognitive function in women with and without polycystic ovary syndrome. Archives of Women's Mental Health. Advance online publication. doi: 10.1007/s00737-021-01158-9
Journal - Research Article
Eggleston, M. J. F., Thabrew, H., Frampton, C. M. A., Eggleston, K. H. F., & Hennig, S. C. (2019). Obtaining an autism spectrum disorder diagnosis and supports: New Zealand parents’ experiences. Research in Autism Spectrum Disorders, 62, 18-25. doi: 10.1016/j.rasd.2019.02.004
Journal - Research Article
Reeves, S., Eggleston, K., Cort, E., McLachlan, E., Brownings, S., Nair, A., … Howard, R. (2018). Therapeutic D2/3 receptor occupancies and response with low amisulpride blood concentrations in very late-onset schizophrenia-like psychosis (VLOSLP). International Journal of Geriatric Psychiatry, 33(2), 396-404. doi: 10.1002/gps.4758
Journal - Research Article
Douglas, K., Inder, M. L., Crowe, M. T., Jordan, J., Carlye, D., Lacey, C., Beaglehole, B., Mulder, R., Eggleston, K., Donovan, K. A., Frampton, C. M. A., … Porter, R. J. (2022). Randomised controlled trial of Interpersonal and Social Rhythm Therapy and group-based Cognitive Remediation versus Interpersonal and Social Rhythm Therapy alone for mood disorders: Study protocol. BMC Psychiatry, 22, 115. doi: 10.1186/s12888-022-03747-z
Journal - Research Other
Crowe, M., Eggleston, K., Douglas, K., & Porter, R. J. (2021). Effects of psychotherapy on comorbid bipolar disorder and substance use disorder: A systematic review. Bipolar Disorders, 23(2), 141-151. doi: 10.1111/bdi.12971
Journal - Research Other
Douglas, K. M., Fenton, A. J., Eggleston, K., & Porter, R. J. (2021). Rate of polycystic ovary syndrome in mental health disorders: A systematic review. Archives of Women's Mental Health. Advance online publication. doi: 10.1007/s00737-021-01179-4
Journal - Research Other
Eggleston, K., & Myles, H. (2021). Advice to potential academics from researchers who have seen 'et al.'. Australian & New Zealand Journal of Psychiatry, 55(3), 235-238. doi: 10.1177/0004867420972757
Journal - Research Other
Eggleston, K., & Porter, R. (2021). Cognitive screening in electroconvulsive therapy: Don't forget subjective cognition. Australian & New Zealand Journal of Psychiatry, 55(12), 1125-1126. doi: 10.1177/0004867421998784
Journal - Research Other
Eggleston, K., & Porter, R. (2021). Lymphadenopathy: A rare but important side effect of lamotrigine. Australian & New Zealand Journal of Psychiatry. Advance online publication. doi: 10.1177/00048674211011260
Journal - Research Other
Crowe, M., Porter, R., Eggleston, K., & Douglas, K. (2020). Addressing cognitive impairment in mood disorders: A role for the mental health nurse. Journal of Psychiatric & Mental Health Nursing, 27, 319-320. doi: 10.1111/jpm.12613
Journal - Research Other
Eggleston, K., & Porter, R. (2020). Subjective memory impairment after electroconvulsive therapy: Potentially modifiable? BJPsych Open, 6(3), e38. doi: 10.1192/bjo.2020.20
Journal - Research Other
Porter, R. J., & Eggleston, K. (2020). Neurocognitive effects of electroconvulsive therapy: What do patients and clinicians need to know? American Journal of Geriatric Psychiatry, 28(3), 317-319. doi: 10.1016/j.jagp.2019.10.017
Journal - Research Other
